NeuroVive Pharmaceutical AB Год IPO
Что обозначает Год IPO в NeuroVive Pharmaceutical AB?
Год IPO NeuroVive Pharmaceutical AB является 2020
Какое определение для Год IPO?
Первичное публичное размещение акций - это тип публичного предложения, при котором акции компании обычно продаются институциональным инвесторам, которые, в свою очередь, впервые продают эти акции широкой публике на фондовой бирже.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Год IPO компаний в Miscellaneous сектор на LSE по сравнению с NeuroVive Pharmaceutical AB
Что делает NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Компании с год ipo похож на NeuroVive Pharmaceutical AB
- Acusensus Ltd имеет Год IPO из 2019
- Grayscale Ethereum Trust (ETH) имеет Год IPO из 2019
- Powerwrap Ltd имеет Год IPO из 2019
- Powerwrap имеет Год IPO из 2019
- National Rural Utilities Cooper имеет Год IPO из 2019
- Listed Funds Trust имеет Год IPO из 2019
- NeuroVive Pharmaceutical AB имеет Год IPO из 2020
- Globally Local Technologies имеет Год IPO из 2021
- uniQure N.V имеет Год IPO из 2021
- Trustpilot plc имеет Год IPO из 2021
- IQVIA имеет Год IPO из 2021
- ACTIA S.A имеет Год IPO из 2021
- Remark имеет Год IPO из 2021